ZNF266
Zinc finger protein 266
Also known as: HZF1, ZN266_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14584
- Gene
- ZNF266
- Ensembl
- ENSG00000174652
- Chromosome
- 19
- Canonical length
- 549 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles,Rods & Rings
OverviewNCBI Gene
This gene encodes a protein containing many tandem zinc-finger motifs. Zinc fingers are protein or nucleic acid-binding domains, and may be involved in a variety of functions, including regulation of transcription. This gene is located in a cluster of similar genes encoding zinc finger proteins on chromosome 19. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Sep 2012]
Canonical amino-acid sequenceUniProt
549 residues, UniProt reviewed canonical sequence.
>Q14584|ZNF266
1 MLENYKNLAT VGYQLFKPSL ISWLEQEESR TVQRGDFQAS EWKVQLKTKE LALQQDVLGE
61 PTSSGIQMIG SHNGGEVSDV KQCGDVSSEH SCLKTHVRTQ NSENTFECYL YGVDFLTLHK
121 KTSTGEQRSV FSQCGKAFSL NPDVVCQRTC TGEKAFDCSD SGKSFINHSH LQGHLRTHNG
181 ESLHEWKECG RGFIHSTDLA VRIQTHRSEK PYKCKECGKG FRYSAYLNIH MGTHTGDNPY
241 ECKECGKAFT RSCQLTQHRK THTGEKPYKC KDCGRAFTVS SCLSQHMKIH VGEKPYECKE
301 CGIAFTRSSQ LTEHLKTHTA KDPFECKICG KSFRNSSCLS DHFRIHTGIK PYKCKDCGKA
361 FTQNSDLTKH ARTHSGERPY ECKECGKAFA RSSRLSEHTR THTGEKPFEC VKCGKAFAIS
421 SNLSGHLRIH TGEKPFECLE CGKAFTHSSS LNNHMRTHSA KKPFTCMECG KAFKFPTCVN
481 LHMRIHTGEK PYKCKQCGKS FSYSNSFQLH ERTHTGEKPY ECKECGKAFS SSSSFRNHER
541 RHADERLSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF266 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 50 nTPM
- spleen: 40 nTPM
- prostate: 28 nTPM
- tonsil: 26 nTPM
- small intestine: 26 nTPM
- thymus: 26 nTPM
Single-cell type
- nk-cells: 56 nCPM
- lactotrophs: 44 nCPM
- sertoli cells: 44 nCPM
- innate lymphoid cells: 39 nCPM
- somatotrophs: 38 nCPM
- renal collecting duct intercalated cells: 35 nCPM
Immune cell
- NK-cell: 11 nTPM
- gdT-cell: 9.6 nTPM
- naive CD8 T-cell: 8.1 nTPM
- naive CD4 T-cell: 7.5 nTPM
- T-reg: 7.5 nTPM
- memory CD8 T-cell: 7.3 nTPM
Brain region
- cerebellum: 10 nTPM
- choroid plexus: 10 nTPM
- white matter: 8.9 nTPM
- thalamus: 7.6 nTPM
- basal ganglia: 7.5 nTPM
- midbrain: 7.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0.02
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF266 as an antibody target. Whether an autoantibody or antibody against ZNF266 could matter depends on whether native ZNF266 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF266 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF266 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...